Aspen Aerogels Q3 net loss widens on incident-related costs
Overview
US sustainability solutions firm's Q3 2026 revenue rose 17% yr/yr, exceeding high end of outlook
Adjusted EBITDA for Q3 2026 was above the high end of company outlook
Net loss widened due to incident-related costs and asset write-down
Outlook
Aspen Aerogels expects Q4 2026 revenue between $60 mln and $75 mln
Company forecasts Q4 2026 net loss between $11 mln and $8 mln
Aspen Aerogels sees Q4 2026 adjusted EBITDA between $5 mln and $13 mln
Result Drivers
ENERGY INDUSTRIAL DELIVERIES - Co said robust Energy Industrial segment deliveries contributed to Q3 growth
EUROPEAN OEM DEMAND - Record European OEM revenue in Thermal Barrier segment drove growth, per co
NEW MARKET ENTRY - Initial Energy Industrial order for data center infrastructure project opened new market opportunity
Company press release:
Key Details
Metric | Beat/Miss | Actual | Consensus Estimate |
Q3 Loss Per Share | $0.13 | ||
Q3 Net Loss | $10.4 mln |
Analyst Coverage
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 4 "strong buy" or "buy", 1 "hold" and 1 "sell" or "strong sell"
The average consensus recommendation for the specialty chemicals peer group is "buy"
Wall Street's median 12-month price target for Aspen Aerogels, Inc. is $7.75, about 61.5% above its November 4 closing price of $4.80
Reuters Recommended Reads
Nov 3 - EnPro beats Q3 sales, profit estimates on semiconductor demand, outlook raised
Nov 3 - AMETEK Q3 sales beat estimates, raises outlook
Nov 3 - Mayville Engineering Q3 revenue beats on Datacenter & Critical Power demand
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)